If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

TARS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 33.08%

Insider Buying (Last 12 Months): $1,646,608.00

Insider Selling (Last 12 Months): $3,109,487.97

Tarsus Pharmaceuticals Insider Trading History Chart

Tarsus Pharmaceuticals Share Price & Price History

^$12.14

▲ +0.1 (0.83%)

As of 03/23/2023 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

Tarsus Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/22/2023	Bobak R. Azamian	CEO	Sell	709	$12.64	$8,961.76	9,334
3/22/2023	Bryan Wahl	General Counsel	Sell	357	$12.64	$4,512.48	16,773
3/22/2023	Jose M Trevejo	Insider	Sell	529	$12.64	$6,686.56	6,572
3/22/2023	Leonard M Greenstein	CFO	Sell	332	$12.64	$4,196.48	32,131
3/22/2023	Seshadri Neervannan	COO	Sell	379	$12.64	$4,790.56	55,086
3/20/2023	Bobak R. Azamian	CEO	Sell	741	$12.61	$9,344.01	10,722
3/20/2023	Bryan Wahl	General Counsel	Sell	357	$12.61	$4,501.77	17,480
3/20/2023	Jose M Trevejo	Insider	Sell	530	$12.61	$6,683.30	7,620
3/20/2023	Leonard M Greenstein	CFO	Sell	333	$12.61	$4,199.13	32,789
3/20/2023	Mark J Holdbrook	VP	Sell	198	$12.61	$2,496.78	3,191
3/20/2023	Seshadri Neervannan	COO	Sell	380	$12.61	$4,791.80	55,837
3/17/2023	Bobak R. Azamian	CEO	Sell	795	$13.28	$10,557.60	11,463
3/16/2023	Bryan Wahl	General Counsel	Sell	337	$13.43	$4,525.91	18,176
3/16/2023	Dianne C Whitfield	Insider	Sell	313	$13.43	$4,203.59	12,872
3/16/2023	Leonard M Greenstein	CFO	Sell	5,313	$13.44	$71,406.72	33,438
3/16/2023	Mark J Holdbrook	VP	Sell	187	$13.43	$2,511.41	3,577
3/16/2023	Seshadri Neervannan	COO	Sell	357	$13.43	$4,794.51	56,577
3/15/2023	Bobak R. Azamian	CEO	Sell	8,000	$13.79	$110,320.00	1,080,536
3/8/2023	Bobak R. Azamian	CEO	Sell	4,853	$15.02	$72,892.06	1,089,253
2/8/2023	Bobak R. Azamian	CEO	Sell	9,000	$15.14	$136,260.00	1,102,106
1/23/2023	Bobak R. Azamian	CEO	Sell	4,856	$15.45	$75,025.20	1,111,106
1/20/2023	Bobak R. Azamian	CEO	Sell	240	$15.00	$3,600.00	1,116,373
1/19/2023	Leonard M Greenstein	CFO	Sell	5,000	$14.56	$72,800.00	39,289
1/18/2023	Bobak R. Azamian	CEO	Sell	8,000	$14.56	$116,480.00	1,116,613
1/11/2023	Bobak R. Azamian	CEO	Sell	3,904	$15.11	$58,989.44	1,124,613
1/9/2023	Bobak R. Azamian	CEO	Sell	729	$15.15	$11,044.35	1,129,422
1/6/2023	Bobak R. Azamian	CEO	Sell	411	$15.00	$6,165.00	1,129,740
12/21/2022	Bobak R. Azamian	CEO	Sell	8,000	$14.57	$116,560.00	1,130,151
12/16/2022	Bobak R. Azamian	CEO	Sell	535	$15.01	$8,030.35	1,138,151
12/15/2022	Leonard M Greenstein	CFO	Sell	5,000	$14.64	$73,200.00	44,289
12/14/2022	Bobak R. Azamian	CEO	Sell	6,420	$15.08	$96,813.60	1,138,686
12/2/2022	Dianne C Whitfield	Insider	Sell	1,154	$16.90	$19,502.60	8,723
11/30/2022	Bryan Wahl	General Counsel	Sell	1,183	$16.50	$19,519.50	16,041
11/30/2022	Dianne C Whitfield	Insider	Sell	1,182	$16.50	$19,503.00	11,042
11/15/2022	Aziz Mottiwala	Insider	Sell	6,857	$17.72	$121,506.04	49,729
10/20/2022	Leonard M Greenstein	CFO	Sell	5,000	$15.92	$79,600.00	54,289
10/19/2022	Bobak R. Azamian	CEO	Sell	8,000	$16.92	$135,360.00	1,162,106
10/12/2022	Bobak R. Azamian	CEO	Sell	9,000	$15.91	$143,190.00	1,170,106
9/21/2022	Bobak R. Azamian	CEO	Sell	8,000	$16.31	$130,480.00	1,179,106
9/15/2022	Leonard M Greenstein	CFO	Sell	5,000	$16.03	$80,150.00	59,289
9/14/2022	Bobak R. Azamian	CEO	Sell	9,000	$16.01	$144,090.00	1,187,106
9/14/2022	Elizabeth Yeu Lin	Director	Buy	18,400	$16.12	$296,608.00	12,040
8/18/2022	Leonard M Greenstein	CFO	Sell	5,000	$16.30	$81,500.00	64,289
8/17/2022	Bobak R. Azamian	CEO	Sell	8,000	$16.59	$132,720.00	1,196,106
5/5/2022	D. Michael Ackermann	Director	Buy	100,000	$13.50	$1,350,000.00	100,000
5/4/2022	Vivo Capital Ix, Llc	Major Shareholder	Sell	19,738	$12.67	$250,080.46	2,474,375
5/2/2022	Vivo Capital Ix, Llc	Major Shareholder	Sell	41,800	$15.19	$634,942.00	2,945,531
12/1/2021	D. Michael Ackermann	Director	Sell	5,833	$24.68	$143,958.44
11/8/2021	Aziz Mottiwala	Insider	Sell	1,889	$28.11	$53,099.79
11/4/2021	Aziz Mottiwala	Insider	Sell	100	$28.03	$2,803.00
11/2/2021	Aziz Mottiwala	Insider	Sell	6,000	$26.78	$160,680.00
11/1/2021	D. Michael Ackermann	Director	Sell	5,833	$27.82	$162,274.06
10/12/2021	Bobak R. Azamian	CEO	Sell	5,531	$26.30	$145,465.30
10/12/2021	D. Michael Ackermann	Director	Sell	5,633	$26.27	$147,978.91
10/8/2021	Bobak R. Azamian	CEO	Sell	302	$25.02	$7,556.04
10/8/2021	D. Michael Ackermann	Director	Sell	200	$25.03	$5,006.00
9/10/2021	Aziz Mottiwala	Insider	Sell	2,593	$22.15	$57,434.95	58,203
9/1/2021	D. Michael Ackermann	Director	Sell	5,833	$25.24	$147,224.92	1,221,515
8/11/2021	Bobak R. Azamian	CEO	Sell	1,917	$25.07	$48,059.19	1,750
8/11/2021	D. Michael Ackermann	Director	Sell	621	$25.15	$15,618.15	1,227,348
8/9/2021	Bobak R. Azamian	CEO	Sell	827	$25.02	$20,691.54	1,750
8/9/2021	D. Michael Ackermann	Director	Sell	700	$25.00	$17,500.00
8/6/2021	D. Michael Ackermann	Director	Sell	3,129	$25.00	$78,225.00
8/5/2021	Bobak R. Azamian	CEO	Sell	1,370	$25.00	$34,250.00
6/25/2021	Vivo Capital Ix, Llc	Major Shareholder	Sell	7,704	$29.60	$228,038.40
6/23/2021	Vivo Capital Ix, Llc	Major Shareholder	Sell	37,980	$29.80	$1,131,804.00
6/21/2021	Vivo Capital Ix, Llc	Major Shareholder	Sell	91,620	$29.70	$2,721,114.00
5/7/2021	Rtw Investments, Lp	Major Shareholder	Sell	450,000	$29.98	$13,491,000.00
4/14/2021	Vivo Capital Ix, Llc	Major Shareholder	Sell	400	$30.37	$12,148.00
10/20/2020	Jason E Tester	Director	Buy	171,875	$16.00	$2,750,000.00
10/20/2020	Vivo Capital Fund Ix, L.P.	Major Shareholder	Buy	250,000	$16.00	$4,000,000.00

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for Tarsus Pharmaceuticals (NASDAQ:TARS)

76.82% of Tarsus Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Tarsus Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/15/2023	State of Wisconsin Investment Board	17,364	$0.26M	0.0%	N/A	0.065%
2/15/2023	Tang Capital Management LLC	2,001,585	$29.34M	4.3%	-4.2%	7.505%
2/15/2023	Legal & General Group Plc	6,903	$0.10M	0.0%	+182.9%	0.026%
2/15/2023	Alps Advisors Inc.	18,076	$0.27M	0.0%	N/A	0.068%
2/15/2023	Jefferies Financial Group Inc.	445,758	$6.54M	0.0%	N/A	1.671%
2/13/2023	Charles Schwab Investment Management Inc.	138,551	$2.03M	0.0%	+1.6%	0.520%
2/13/2023	Callan Capital LLC	11,600	$0.17M	0.0%	N/A	0.043%
2/13/2023	Barclays PLC	7,918	$0.12M	0.0%	+110.5%	0.030%
2/13/2023	Renaissance Technologies LLC	65,600	$0.96M	0.0%	-5.6%	0.246%
2/13/2023	Credit Suisse AG	13,435	$0.20M	0.0%	+12,943.7%	0.050%
2/13/2023	Geode Capital Management LLC	341,191	$5M	0.0%	+3.6%	1.279%
2/13/2023	JPMorgan Chase & Co.	11,351	$0.17M	0.0%	+13.0%	0.043%
2/10/2023	Bank of America Corp DE	15,544	$0.23M	0.0%	+33.8%	0.058%
2/10/2023	TimesSquare Capital Management LLC	1,429,310	$20.95M	0.3%	-6.0%	5.359%
2/9/2023	Dimensional Fund Advisors LP	199,676	$2.93M	0.0%	+40.4%	0.749%
2/8/2023	UBS Group AG	6,858	$0.10M	0.0%	+879.7%	0.026%
2/8/2023	Swiss National Bank	41,833	$0.61M	0.0%	N/A	0.157%
2/1/2023	Janney Montgomery Scott LLC	11,640	$0.17M	0.0%	N/A	0.044%
1/26/2023	Strs Ohio	23,100	$0.34M	0.0%	-17.5%	0.087%
1/12/2023	Assenagon Asset Management S.A.	183,208	$2.69M	0.0%	-9.5%	0.687%
12/8/2022	Bank of New York Mellon Corp	54,148	$0.93M	0.0%	+21.5%	0.203%
11/15/2022	State Street Corp	293,111	$5.02M	0.0%	+23.9%	1.099%
11/15/2022	Public Employees Retirement System of Ohio	5,500	$94K	0.0%	N/A	0.021%
11/15/2022	Jacobs Levy Equity Management Inc.	86,948	$1.49M	0.0%	+6.0%	0.326%
11/15/2022	Tang Capital Management LLC	2,089,856	$35.78M	4.4%	+0.3%	7.835%
11/15/2022	Two Sigma Advisers LP	32,100	$0.55M	0.0%	+202.8%	0.120%
11/15/2022	Two Sigma Investments LP	18,851	$0.32M	0.0%	-26.7%	0.071%
11/15/2022	Vanguard Group Inc.	935,649	$16.02M	0.0%	+42.7%	3.508%
11/15/2022	Prelude Capital Management LLC	16,821	$0.29M	0.0%	-11.7%	0.063%
11/15/2022	Bank of New York Mellon Corp	54,148	$0.93M	0.0%	+21.5%	0.203%
11/15/2022	BlackRock Inc.	1,118,761	$19.15M	0.0%	+10.2%	4.195%
11/14/2022	RTW Investments LP	2,023,179	$34.64M	0.8%	+0.5%	7.585%
11/14/2022	Cormorant Asset Management LP	1,971,422	$33.75M	2.4%	+5.1%	7.391%
11/14/2022	Vivo Capital LLC	2,262,200	$38.73M	4.3%	-2.2%	8.482%
11/14/2022	Renaissance Technologies LLC	69,500	$1.19M	0.0%	+15.3%	0.261%
11/14/2022	Nuveen Asset Management LLC	57,018	$0.98M	0.0%	-3.5%	0.214%
11/14/2022	Rubric Capital Management LP	284,732	$4.88M	0.2%	+40.5%	1.068%
11/14/2022	UBS Oconnor LLC	61,000	$1.04M	0.0%	N/A	0.229%
11/10/2022	Dimensional Fund Advisors LP	142,207	$2.43M	0.0%	+25.9%	0.533%
11/10/2022	Tower Research Capital LLC TRC	1,490	$26K	0.0%	-43.4%	0.006%
11/7/2022	Jump Financial LLC	12,300	$0.21M	0.0%	-48.8%	0.046%
10/27/2022	Sargent Investment Group LLC	10,858	$0.19M	0.1%	N/A	0.041%
10/27/2022	Assenagon Asset Management S.A.	202,425	$3.47M	0.0%	-44.0%	0.759%
10/26/2022	Allspring Global Investments Holdings LLC	10,683	$0.18M	0.0%	-9.9%	0.040%
8/24/2022	Prelude Capital Management LLC	19,049	$0.28M	0.0%	N/A	0.071%
8/18/2022	Goldman Sachs Group Inc.	98,710	$1.44M	0.0%	+249.3%	0.370%
8/17/2022	Macquarie Group Ltd.	172,908	$2.52M	0.0%	N/A	0.649%
8/16/2022	Deerfield Management Company L.P. Series C	1,324,214	$19.33M	0.4%	N/A	4.967%
8/15/2022	State Street Corp	236,516	$3.45M	0.0%	+78.0%	1.141%
8/15/2022	Macquarie Group Ltd.	172,908	$2.52M	0.0%	N/A	0.834%
8/15/2022	Cubist Systematic Strategies LLC	13,669	$0.20M	0.0%	N/A	0.066%
8/15/2022	Vivo Capital LLC	2,312,368	$33.76M	3.4%	-22.6%	11.156%
8/13/2022	Renaissance Technologies LLC	60,300	$0.88M	0.0%	N/A	0.291%
8/13/2022	American International Group Inc.	8,486	$0.12M	0.0%	+102.7%	0.041%
8/12/2022	Northern Trust Corp	139,147	$2.03M	0.0%	+102.4%	0.671%
8/12/2022	Rhumbline Advisers	25,762	$0.38M	0.0%	N/A	0.124%
8/11/2022	Martingale Asset Management L P	14,349	$0.21M	0.0%	N/A	0.069%
8/11/2022	JPMorgan Chase & Co.	9,693	$0.14M	0.0%	+145.1%	0.047%
8/10/2022	Frazier Life Sciences Management L.P.	1,787,527	$26.10M	2.5%	+26.1%	8.624%
8/5/2022	State Board of Administration of Florida Retirement System	13,170	$0.19M	0.0%	N/A	0.064%
8/5/2022	TimesSquare Capital Management LLC	1,481,710	$21.63M	0.3%	+124.6%	7.148%
7/29/2022	SG Americas Securities LLC	50,512	$0.74M	0.0%	+19.0%	0.244%
7/27/2022	Assenagon Asset Management S.A.	361,741	$5.28M	0.0%	N/A	1.745%
7/25/2022	Allspring Global Investments Holdings LLC	11,860	$0.17M	0.0%	-7.1%	0.057%
7/25/2022	Strs Ohio	28,000	$0.41M	0.0%	+1,233.3%	0.135%
6/7/2022	Bank of America Corp DE	6,499	$0.11M	0.0%	-39.0%	0.031%
5/16/2022	California State Teachers Retirement System	3,615	$61K	0.0%	-22.1%	0.017%
5/16/2022	State Street Corp	132,883	$2.24M	0.0%	+2.4%	0.641%
5/16/2022	J. Goldman & Co LP	10,544	$0.18M	0.0%	N/A	0.051%
5/16/2022	Frazier Life Sciences Management L.P.	1,417,157	$23.84M	2.0%	N/A	6.837%
5/16/2022	Ghost Tree Capital LLC	120,000	$2.02M	0.4%	-29.4%	0.579%
5/16/2022	Invesco Ltd.	27,982	$0.47M	0.0%	+17.1%	0.135%
5/16/2022	UBS Group AG	4,226	$71K	0.0%	+37.0%	0.020%
5/13/2022	Northern Trust Corp	68,732	$1.16M	0.0%	-4.2%	0.332%
5/13/2022	Charles Schwab Investment Management Inc.	48,583	$0.82M	0.0%	+3.0%	0.234%
5/13/2022	DLD Asset Management LP	32,500	$0.55M	0.0%	N/A	0.157%
5/13/2022	Dimensional Fund Advisors LP	28,855	$0.49M	0.0%	+221.0%	0.139%
5/12/2022	BlackRock Inc.	439,958	$7.40M	0.0%	-2.0%	2.123%
5/11/2022	JPMorgan Chase & Co.	3,954	$67K	0.0%	-97.7%	0.019%
5/6/2022	TimesSquare Capital Management LLC	659,600	$11.09M	0.1%	-0.2%	3.182%
4/29/2022	SG Americas Securities LLC	42,439	$0.71M	0.0%	-4.3%	0.205%
2/11/2022	Ensign Peak Advisors Inc	242,451	$5.46M	0.0%	+21.2%	1.173%
2/8/2022	Northern Trust Corp	71,781	$1.62M	0.0%	-3.0%	0.347%
2/7/2022	SG Americas Securities LLC	44,330	$1M	0.0%	-4.2%	0.214%
2/4/2022	TimesSquare Capital Management LLC	660,800	$14.87M	0.1%	+1.5%	3.196%
1/28/2022	Allspring Global Investments Holdings LLC	12,885	$0.29M	0.0%	N/A	0.062%
12/17/2021	Jefferies Group LLC	422,993	$9.12M	0.1%	-4.5%	2.046%
11/12/2021	Geode Capital Management LLC	123,698	$2.67M	0.0%	-1.5%	0.601%
11/10/2021	Goldman Sachs Group Inc.	26,480	$0.57M	0.0%	-1.5%	0.129%
11/9/2021	BlackRock Inc.	441,620	$9.52M	0.0%	+0.7%	2.147%
11/8/2021	TimesSquare Capital Management LLC	650,780	$14.02M	0.1%	-5.2%	3.163%
11/4/2021	Sands Capital Ventures LLC	260,000	$5.60M	0.8%	N/A	1.264%
11/2/2021	New York State Common Retirement Fund	5,881	$0.13M	0.0%	-37.1%	0.029%
11/1/2021	SG Americas Securities LLC	46,253	$1M	0.0%	+101.3%	0.225%
8/20/2021	Jefferies Group LLC	442,993	$12.84M	0.1%	N/A	2.153%
8/17/2021	Invesco Ltd.	30,428	$0.88M	0.0%	+4.0%	0.148%
8/16/2021	California State Teachers Retirement System	11,644	$0.34M	0.0%	+25.2%	0.057%
8/16/2021	Charles Schwab Investment Management Inc.	46,573	$1.35M	0.0%	+11.9%	0.226%
8/16/2021	Jefferies Group LLC	442,993	$12.84M	0.1%	N/A	2.153%
8/16/2021	State Street Corp	119,141	$3.45M	0.0%	+18.7%	0.579%

Data available starting January 2016

Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other diseases. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.

Today's Range

Now: $12.14

$11.78

$12.39

50 Day Range

MA: $14.89

$12.04

$16.27

52 Week Range

Now: $12.14

$10.80

$19.66

Volume

53,470 shs

Average Volume

69,759 shs

Market Capitalization

$324.50 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.69

Who are the company insiders with the largest holdings of Tarsus Pharmaceuticals?: Tarsus Pharmaceuticals' top insider shareholders include:
Vivo Capital Ix, Llc (Major Shareholder)
Michael Ackermann (Director)
Bobak R Azamian (CEO)
Leonard M Greenstein (CFO)
Aziz Mottiwala (Insider)
Seshadri Neervannan (COO)
Bryan Wahl (General Counsel)
Dianne C Whitfield (Insider)
Elizabeth Yeu Lin (Director)
Jose M Trevejo (Insider)
Mark J Holdbrook (VP)
Bobak R Azamian (CEO)
Rtw Investments, Lp (Major Shareholder)
Learn More about top insider investors at Tarsus Pharmaceuticals.
Who are the major institutional investors of Tarsus Pharmaceuticals?: Tarsus Pharmaceuticals' top institutional shareholders include:
Tang Capital Management LLC — 7.51%
TimesSquare Capital Management LLC — 5.36%
Jefferies Financial Group Inc. — 1.67%
Geode Capital Management LLC — 1.28%
Dimensional Fund Advisors LP — 0.75%
Assenagon Asset Management S.A. — 0.69%
Learn More about top institutional investors of Tarsus Pharmaceuticals stock.
Which institutional investors are selling Tarsus Pharmaceuticals stock?: Within the last quarter, TARS stock was sold by these institutional investors:
TimesSquare Capital Management LLC
Tang Capital Management LLC
Assenagon Asset Management S.A.
Strs Ohio
Renaissance Technologies LLC
In the last year, company insiders that have sold Tarsus Pharmaceuticals company stock include:
Vivo Capital Ix, Llc (Major Shareholder)
Michael Ackermann (Director)
Bobak R Azamian (CEO)
Leonard M Greenstein (CFO)
Aziz Mottiwala (Insider)
Seshadri Neervannan (COO)
Bryan Wahl (General Counsel)
Dianne C Whitfield (Insider)
Elizabeth Yeu Lin (Director)
Learn More investors selling Tarsus Pharmaceuticals stock.
Which institutional investors are buying Tarsus Pharmaceuticals stock?: In the previous quarter, TARS stock was acquired by institutional investors including:
Jefferies Financial Group Inc.
Dimensional Fund Advisors LP
Swiss National Bank
Alps Advisors Inc.
State of Wisconsin Investment Board
Credit Suisse AG
Geode Capital Management LLC
Janney Montgomery Scott LLC
Within the last year, these company insiders have bought Tarsus Pharmaceuticals stock:
Vivo Capital Ix, Llc (Major Shareholder)
Michael Ackermann (Director)
Learn More investors buying Tarsus Pharmaceuticals stock.

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

TARS Insider Trading

Tarsus Pharmaceuticals Insider Trading History Chart

Tarsus Pharmaceuticals Share Price & Price History

Tarsus Pharmaceuticals Insider Trading History

SEC Filings (Institutional Ownership Changes) for Tarsus Pharmaceuticals (NASDAQ:TARS)

Institutional Buying and Selling by Quarter

Tarsus Pharmaceuticals Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Tarsus Pharmaceuticals?

Who are the major institutional investors of Tarsus Pharmaceuticals?

Which institutional investors are selling Tarsus Pharmaceuticals stock?

Which institutional investors are buying Tarsus Pharmaceuticals stock?